Urticaria as a dermatologic manifestation of Giardia infection: a systematic review of clinical, diagnostic, and therapeutic features
- PMID: 40890603
- PMCID: PMC12403345
- DOI: 10.1186/s12879-025-11484-3
Urticaria as a dermatologic manifestation of Giardia infection: a systematic review of clinical, diagnostic, and therapeutic features
Abstract
Background: Giardiasis is recognized as the most prevalent enteric protozoal infection worldwide. Although gastrointestinal symptoms are the most common manifestations of giardiasis, several studies have reported cases of urticaria associated with this infection. Urticaria is a common mast cell-dependent disorder characterized by wheals, angioedema, or both. The aim of this study was to conduct the first systematic review to comprehensively synthesize the clinical, diagnostic, and therapeutic features of urticaria as a dermatologic manifestation in patients with giardiasis.
Methods: This review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement. PubMed/MEDLINE, Web of Science, Scopus, ScienceDirect, and Google Scholar were searched without language restrictions up to 2025 to identify articles reporting patients with urticaria and giardiasis.
Results: Thirteen papers describing a total of 23 patients (14 males and 9 females, aged 4 to 56 years) were included. The locations of urticarial lesions varied, involving the head, trunk, and extremities. The duration of urticaria ranged from 8 h to 8 months. Other clinical manifestations reported in the patients included diarrhea, pruritus, abdominal distension, arthropathy, anorexia, headache, vomiting, abdominal pain, and dysphagia. Increased Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), elevated Immunoglobulin E (IgE), eosinophilia, stool examination, and Enzyme-linked immunosorbent assay (ELISA) were among the diagnostic tests utilized. Metronidazole, tinidazole, and quinacrine hydrochloride were the most commonly prescribed medications for treatment.
Conclusions: Our review highlights the diversity of clinical presentations and diagnostic approaches, and, for the first time, provides a consolidated resource for clinicians encountering this uncommon extraintestinal manifestation of giardiasis. In the initial evaluation of patients presenting with urticaria and a history of gastrointestinal symptoms, particularly those residing in areas with poor hygiene, potential exposure to contaminated water, or recent travel to such regions, parasitic infections, especially giardiasis, should be considered among the differential diagnoses. By addressing this under-recognized association, our study fills a significant knowledge gap regarding urticaria associated with giardiasis, ultimately facilitating earlier diagnosis, appropriate treatment, and improved patient prognosis.
Keywords: Giardia infection; Allergy; Angioedema; Giardiasis; Systematic review; Urticaria.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval and consent to participate were not applicable, as this systematic review was based on published literature. This study was conducted in accordance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.Clin Gastroenterol Hepatol. 2025 Jul;23(8):1291-1302. doi: 10.1016/j.cgh.2025.02.015. Epub 2025 May 19. Clin Gastroenterol Hepatol. 2025. PMID: 40387691 Review.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Systemic treatments for eczema: a network meta-analysis.Cochrane Database Syst Rev. 2020 Sep 14;9(9):CD013206. doi: 10.1002/14651858.CD013206.pub2. Cochrane Database Syst Rev. 2020. PMID: 32927498 Free PMC article.
-
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.Health Technol Assess. 2012;16(17):1-266. doi: 10.3310/hta16170. Health Technol Assess. 2012. PMID: 22469073 Free PMC article.
References
-
- Dunn N, Juergens AL. Giardiasis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
-
- Leung AKC, Leung AAM, Wong AHC, Sergi CM, Kam JKM. Giardiasis: an overview. Recent Pat Inflamm Allergy Drug Discov. 2019;13(2):134–43. 10.2174/1872213x13666190618124901. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous